As we see the steady — and hopefully permanent — decline of COVID-19 in the U.S., the challenge for the long-term care industry is a comeback. What we can expect is that the comeback will not look...
A tough retirement nest egg, the whistle-blowing way
By
James M. Berklan
Nov 07, 2013
Two big reactions hit me when news of Johnson & Johnson’s $2.2 billion Risperdal settlement with the government landed this week. First, J&J probably made a lot more than it’s paying out and,...
David fights on after long-term care Goliath decides to bow out
By
James M. Berklan
Aug 29, 2012
The headlines were big. Really big. And they involved a long-term care corporate giant settling yet another lawsuit. But they didn’t tell the story I really wanted to know about. And that you probably...